高效液相色谱-大气压化学电离串联质谱法研究4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮体外模拟代谢作用

范腾蛟; 赵丽娇; 张然; 钟儒刚

doi:10.7538/zpxb.youxian.2014.0038

高效液相色谱-大气压化学电离串联质谱法研究4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮体外模拟代谢作用

北京工业大学生命科学与生物工程学院,环境与病毒肿瘤学北京市重点实验室,北京100124

计量
- 文章访问数: 985
- HTML全文浏览量: 2
- PDF下载量: 970
出版历程
- 刊出日期: 2014-11-19

Study on In vitro Simulation of the Metabolism of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Using HPLC-APCI-MS/MS

Beijing Key Laboratory of Environmental & Viral Oncology, College of Life Science & Bioengineering, Beijing University of Technology, Beijing 100124, China

摘要

摘要: 烟草特异亚硝胺4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)是一种存在于烟草烟气及烟草制品中的强致癌物，其致癌机理是通过细胞色素P450酶的代谢活化生成活泼亲电试剂，导致DNA损伤，因此，建立NNK体外模拟代谢产物的定量分析方法对于研究烟草致癌物具有重要意义。本实验利用高效液相色谱-大气压化学电离串联质谱法（HPLC-APCI-MS/MS）对NNK代谢产物4-羟基-1-(3-吡啶基)-1-丁酮(HPB)进行定量分析。使用选择反应扫描（SRM）模式监测了HPB和内标[3,3,4,4-D₄]HPB，分析方法在0.2~400 nmol/L范围内线性关系良好，线性相关系数R²=0.999 9，检出限(LOD)为0.025 nmol/L (S/N=3)，定量限(LOQ)为0.05 nmol/L(S/N=10)。方法的日内和日间准确度为96.6%~101.8%，回收率为98.1%~102.6%。所建立的NNK体外模拟代谢模型可用于烟草特异亚硝胺代谢活化分子机制的研究，为定量分析吸烟致癌相关生物标志物奠定基础。
Abstract: Tobacoo-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen present in tobacco products and tobacco smoke. The carcinogenic mechanism of NNK is involved in the DNA damage induced by the active electrophiles generated from the metabolic activation of NNK catalyzed by cytochrome P450. It is significant to establish an in vitro metabolism model of NNK and the quantitation method for the investigation of tabacco carcinogens motabolites. In this work, the NNK metabolite of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) was quantitatively analyzed by high performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry (HPLC-APCI-MS/MS). Selective reaction monitoring (SRM) was employed for determining HPB and the internal standard [3,3,4,4-D₄]HPB simultaneously. The method shows good linearity within 0.2—400 nmol/L with the correlation coefficient (R₂) 0.999 9. The limit of detection (LOD) and the limit of quantitation (LOQ) are 0.025 nmol/L (S/N=3) and 0.05 nmol/L (S/N=10), respectively. The inter-day and intraday accuracy range from 96.6% to 101.8%, and the recovery is 98.1%—102.6%. The in vitro metabolism model of NNK can be used to elucidate the molecular mechanism of the metabolic activation of tobaccospecific nitrosamine. This work layed a foundation for the quantification of biomarkers for tobacco carcinogenesis.

HTML全文

参考文献(17)

[1]	HECHT S S. Biochemistry, biology, and carcinogenicity of tobacco-specific n-nitrosamines [J]. Chemical Research in Toxicology, 1998, 11(6): 559-603.
[2]	HECHT S S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer [J]. Nature Reviews Cancer, 2003, 3(10): 733-744.
[3]	IARC. Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco habits other than smoking: Betel quid and areca nut chewing and some related nitrosamines [R]. International Agency for Research on Cancer, Lyon, France，1985, 37: 1-268.
[4]	IARC. Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Smokeless tobacco and some tobacco-specific n-nitrosamines [R]. International Agency for Research on Cancer, Lyon, France，2007, 89: 1-592.
[5]	HECHT S S. Tobacco smoke carcinogens and lung-cancer [J]. Journal of the National Cancer Institute, 1999, 91(14): 1194-1210.
[6]	SU T, BAO Z P, ZHANG Q Y, et al. Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [J]. Cancer Research, 2000, 60(18): 5074-5079.
[7]	JALAS J R, DING X X, MURPHY S E. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13 [J]. Drug Metabolism and Disposition, 2003, 31(10): 1199-1202.
[8]	PATTEN C J, SMITH T J, MURPHY S E, et al. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes [J]. Archives of Biochemistry and Biophysics, 1996, 333(1): 127-138.
[9]	MESSINA E S, TYNDALE R F, SELLERS E M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes [J]. Journal of Pharmacology and Experimental Therapeutics, 1997, 282(3): 1608-1614.
[10]	SMITH T J, GUO Z, HONG J Y, et al. Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal-mucosa [J]. Carcinogenesis, 1992, 13(8): 1409-1414.
[11]	MULLETT W M, LEVSEN K, BORLAK J, et al.Automated in-tube solid-phase microextraction coupled with HPLC for the determination of n-nitrosamines in cell cultures [J]. Analytical Chemistry, 2002, 74(7): 1695-1701.
[12]	LEE H L, WANG C Y, LIN S, et al. Liquid chromatography tandem mass spectrometric method for the simultaneous determination of tobacco-specific nitrosamine NNK and its five metabolites [J]. Talanta, 2007, 73(1): 76-80.
[13]	CHIANG H C, WANG C Y, LEE H L, et al. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation-A mammalian cell-based mutagenesis approach [J]. Toxicology and Applied Pharmacology, 2011, 253(2): 145-152.
[14]	LANG H L, WANG S, ZHANG Q D, et al. Simultaneous determination of NNK and its seven metabolites in rabbit blood by hydrophilic interaction liquid chromatography-tandem mass spectrometry [J]. Analytical and Bioanalytical Chemistry, 2013, 405(6): 2083-2089.
[15]	WANG M Y, CHENG G, STURLA S J, et al. Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosa mino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens [J]. Chemical Research in Toxicology, 2003, 16(5): 616-626.
[16]	STURLA S J, SCOTT J, LAO Y B, et al. Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone[J]. Chemical Research in Toxicology, 2005, 18(6): 1048-1055.
[17]	RICHTER E, ENGL J, FRIESENEGGER S, et al.Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man [J]. Chemical Research in Toxicology, 2009, 22(6): 1008-1017.

施引文献

资源附件(0)

计量

文章访问数: 985
HTML全文浏览量: 2
PDF下载量: 970
被引次数: 0

高效液相色谱-大气压化学电离串联质谱法研究4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮体外模拟代谢作用

计量

出版历程

Study on In vitro Simulation of the Metabolism of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Using HPLC-APCI-MS/MS

计量

出版历程

目录